phenytoin has been researched along with Tremor in 30 studies
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rats given a tremorigenic dose of DDT (75 mg/kg, PO) were treated with pharmacological agents either 30 min prior to DDT or 1-2 h prior to testing at the time of peak effect (12 h postdosing)." | 7.67 | DDT-induced tremor in rats: effects of pharmacological agents. ( Herr, DW; Hong, JS; Tilson, HA, 1985) |
| " Reversible dystonia may occasionally be precipitated by phenytoin or carbamazepine; asterixis by phenytoin, barbiturates or carbamazepine; and, more commonly, tremor by valproate." | 4.77 | Adverse neuropsychiatric effects of anticonvulsant drugs. ( Reynolds, EH; Trimble, MR, 1985) |
| " Pimprinine also inhibited effectively tremorine-induced tremors and analgesia in mice." | 3.71 | Pimprinine, an extracellular alkaloid produced by Streptomyces CDRIL-312: fermentation, isolation and pharmacological activity. ( Harindran, J; Naik, SR; Varde, AB, 2001) |
| "We demonstrated that stereotyped behavior and tremor induced by methamphetamine (MA) were potentiated by pretreatment with phenytoin (PNT) in mice." | 3.67 | Phenytoin potentiates methamphetamine-induced behavior in mice. ( Fukuda, T; Izumi, K; Kishita, C; Koja, T; Nomoto, M; Shimizu, T, 1984) |
| "Rats given a tremorigenic dose of DDT (75 mg/kg, PO) were treated with pharmacological agents either 30 min prior to DDT or 1-2 h prior to testing at the time of peak effect (12 h postdosing)." | 3.67 | DDT-induced tremor in rats: effects of pharmacological agents. ( Herr, DW; Hong, JS; Tilson, HA, 1985) |
| " The pharmacokinetic assessment was repeated on day 18." | 2.69 | Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin. ( Boellner, SW; Cao, GX; Cato, A; Guenther, HJ; Gustavson, LE; Qian, JX; Sommerville, KW, 1998) |
| " A nasogastric tube was immediately placed and the patient received treatment with a chelating agent dimercaptosuccinic acid (DMSA)/succimer 800 mg orally three times a day, a dosage decided on the basis of her body weight, plus phenytoin 125 mg intravenously three times a day." | 1.42 | Elemental mercury mixed with alcohol injected intravenously as a suicide attempt. ( Karatapanis, S; Kotis, A; Lamprianou, F; Ntetskas, G, 2015) |
| "Pretreatment with phenytoin significantly attenuated the tremor produced by p,p'-DDT but enhanced that produced by chlordecone." | 1.27 | 5,5-Diphenylhydantoin antagonizes neurochemical and behavioral effects of p,p'-DDT but not of chlordecone. ( Hong, JS; Hudson, PM; Tilson, HA, 1986) |
| "Pretreatment with phenytoin significantly reduced the tremor and hyperresponsiveness produced by p,p'-DDT and permethrin." | 1.27 | Effects of 5,5-diphenylhydantoin (phenytoin) on neurobehavioral toxicity of organochlorine insecticides and permethrin. ( Hong, JS; Mactutus, CF; Tilson, HA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (76.67) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 2 (6.67) | 29.6817 |
| 2010's | 2 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balsamo, A | 1 |
| Barili, PL | 1 |
| Crotti, P | 1 |
| Macchia, B | 1 |
| Macchia, F | 1 |
| Cuttica, A | 1 |
| Passerini, N | 1 |
| Zappia, CP | 1 |
| Piccirillo, B | 1 |
| Karatapanis, S | 1 |
| Lamprianou, F | 1 |
| Ntetskas, G | 1 |
| Kotis, A | 1 |
| Raskin, DE | 1 |
| Izumi, K | 1 |
| Nomoto, M | 1 |
| Koja, T | 1 |
| Shimizu, T | 1 |
| Kishita, C | 1 |
| Fukuda, T | 1 |
| Kadanka, Z | 1 |
| Ishii, K | 1 |
| Hayashi, A | 1 |
| Tamaoka, A | 1 |
| Usuki, S | 1 |
| Mizusawa, H | 1 |
| Shoji, S | 1 |
| Reutens, DC | 1 |
| Duncan, JS | 1 |
| Patsalos, PN | 1 |
| Gustavson, LE | 1 |
| Cato, A | 1 |
| Boellner, SW | 1 |
| Cao, GX | 1 |
| Qian, JX | 1 |
| Guenther, HJ | 1 |
| Sommerville, KW | 1 |
| Naik, SR | 1 |
| Harindran, J | 1 |
| Varde, AB | 1 |
| Türkdogan, D | 1 |
| Onat, F | 1 |
| Türe, U | 1 |
| Pamir, N | 1 |
| Boldyrev, AI | 1 |
| Fleĭs, EP | 1 |
| Vaĭntrub, MIa | 1 |
| Speirs, J | 1 |
| Hirsch, SR | 1 |
| Gitlin, N | 1 |
| Morris, HB | 1 |
| Chadwick, D | 1 |
| Reynolds, EH | 2 |
| Marsden, CD | 1 |
| Raskin, NH | 1 |
| Fishman, RA | 1 |
| Banna, NR | 1 |
| Kurkjian, R | 1 |
| Tilson, HA | 3 |
| Hudson, PM | 1 |
| Hong, JS | 3 |
| Trimble, MR | 1 |
| Ramsay, RE | 1 |
| Herr, DW | 1 |
| Mactutus, CF | 1 |
| Jus, K | 1 |
| Jus, A | 1 |
| Villeneuve, A | 1 |
| Murphy, MJ | 1 |
| Goldstein, MN | 1 |
| Shuttleworth, E | 1 |
| Wise, G | 1 |
| Paulson, G | 1 |
| Moss-Herjanic, B | 1 |
| Holcomb, R | 1 |
| Lynn, R | 1 |
| Harvey, B | 1 |
| Sweetman, BJ | 1 |
| Gerber, N | 1 |
| Ideström, CM | 1 |
| Schalling, D | 1 |
| Carlquist, U | 1 |
| Sjöqvist, F | 1 |
| Schussler, GC | 1 |
| Glatt, MM | 1 |
| George, HR | 1 |
| Frisch, EP | 1 |
3 reviews available for phenytoin and Tremor
| Article | Year |
|---|---|
Neurologic disorders in renal failure (first of two parts).
Topics: Blood-Brain Barrier; Brain Diseases; Cerebrospinal Fluid Proteins; Diazepam; Epilepsy; Humans; Lidoc | 1976 |
Adverse neuropsychiatric effects of anticonvulsant drugs.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Barbiturates; Benzodiazepines; Biogenic Amines; Carba | 1985 |
Use of phenytoin and carbamazepine in treatment of epilepsy.
Topics: Anemia, Aplastic; Carbamazepine; Cerebellar Ataxia; Chemical and Drug Induced Liver Injury; Cognitio | 1986 |
3 trials available for phenytoin and Tremor
| Article | Year |
|---|---|
Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dizziness; Drug Interactions; Drug Monitoring; Dr | 1998 |
Acute effects of diphenylhydantoin in relation to plasma levels. Behavioral and psychophysiological studies.
Topics: Adult; Affect; Attention; Behavior; Differential Threshold; Electric Stimulation; Flicker Fusion; Ga | 1972 |
Evaluation of chlormethiazole in treatment for alcohol withdrawal syndrome. Results of a controlled trial.
Topics: Alcoholism; Chlormethiazole; Clinical Trials as Topic; Depression; Female; Humans; Hypertension; Hyp | 1966 |
24 other studies available for phenytoin and Tremor
| Article | Year |
|---|---|
Structure-activity relationship in cinnamamides. 2. Synthesis and pharmacological evaluation of some (E)- and (Z)-N-alkyl-alpha, beta-dimethylcinnamamides substituted on the phenyl group.
Topics: Alkylation; Amides; Animals; Anticonvulsants; Behavior, Animal; Cinnamates; Drug Evaluation; Magneti | 1977 |
Ataxia and dizziness in a patient on hemodialysis.
Topics: Anticonvulsants; Ataxia; Dizziness; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phenytoin; R | 2014 |
Elemental mercury mixed with alcohol injected intravenously as a suicide attempt.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Chelating Agents; Confusion; Ethanol; Female; H | 2015 |
Lithium and phenytoin interaction.
Topics: Anxiety Disorders; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; | 1984 |
Phenytoin potentiates methamphetamine-induced behavior in mice.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Carbamazepine; Drug Synergism; Humans; Male; Methamph | 1984 |
[The effect of hydantoins on normal postural tremor].
Topics: Adult; Female; Humans; Phenytoin; Posture; Tremor | 1983 |
Case report: thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto's encephalopathy.
Topics: Adult; Female; Humans; Menstrual Cycle; Myoclonus; Phenytoin; Prolactin; Thyroid Gland; Thyroiditis, | 1995 |
Disabling tremor after lamotrigine with sodium valproate.
Topics: Anticonvulsants; Drug Interactions; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Lamotrigi | 1993 |
Pimprinine, an extracellular alkaloid produced by Streptomyces CDRIL-312: fermentation, isolation and pharmacological activity.
Topics: Animals; Anticonvulsants; Biotechnology; Chromatography, Thin Layer; Dose-Response Relationship, Dru | 2001 |
Phenytoin toxicity with mandibular tremor secondary to intravenous administration.
Topics: Anticonvulsants; Epilepsy, Complex Partial; Humans; Injections, Intravenous; Male; Middle Aged; Phen | 2002 |
[Neurologic complications following medical treatment of epileptic patients].
Topics: Adolescent; Adult; Anticonvulsants; Ataxia; Benzodiazepines; Consciousness Disorders; Dysarthria; Ey | 1979 |
Severe lithium toxicity with "normal" serum concentrations.
Topics: Adult; Humans; Lithium; Male; Phenytoin; Tremor | 1978 |
Flapping tremor associated with administration of diphenylhydantoin sodium.
Topics: Humans; Male; Middle Aged; Phenytoin; Tremor | 1976 |
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Chorea; Dyskinesia, Dr | 1976 |
A novel tremorigen antagonized by D-amphetamine.
Topics: Acetates; Aldehydes; Amines; Animals; Atropine; Calcium; Chlorpromazine; Dextroamphetamine; Diazepam | 1975 |
5,5-Diphenylhydantoin antagonizes neurochemical and behavioral effects of p,p'-DDT but not of chlordecone.
Topics: Animals; Brain Chemistry; Brain Stem; Caudate Nucleus; Chlordecone; DDT; Hippocampus; Hydroxyindolea | 1986 |
DDT-induced tremor in rats: effects of pharmacological agents.
Topics: Analysis of Variance; Animals; DDT; Dose-Response Relationship, Drug; Male; Mephenesin; Phenytoin; P | 1985 |
Effects of 5,5-diphenylhydantoin (phenytoin) on neurobehavioral toxicity of organochlorine insecticides and permethrin.
Topics: Animals; Insecticides; Male; Motor Activity; Permethrin; Phenytoin; Pyrethrins; Rats; Rats, Inbred F | 1985 |
Polygraphic profile of oral tardive dyskinesia and of rabbit syndrome: for quantitative and qualitative evaluation.
Topics: Attention; Basal Ganglia Diseases; Benztropine; Diazepam; Electroencephalography; Electromyography; | 1973 |
Diphenylhydantoin-induced asterixis. A clinical study.
Topics: Ataxia; Electroencephalography; Electromyography; Epilepsy; Female; Humans; Male; Middle Aged; Nysta | 1974 |
Choreoathetosis and diphenylhydantoin intoxication.
Topics: Adolescent; Adult; Ataxia; Athetosis; Chorea; Diplopia; Female; Humans; Male; Nystagmus, Pathologic; | 1974 |
Prolonged unconsciousness following electroconvulsive therapy.
Topics: Adult; Aged; Coma; Craniocerebral Trauma; Depression; Electroconvulsive Therapy; Epilepsies, Partial | 1967 |
Intoxication with 5,5-diphenylhydantoin (Dilantin): clinical features, blood levels, urinary metabolites, and metabolic changes in a child.
Topics: Ataxia; Child, Preschool; Glucuronates; Half-Life; Humans; Hyperglycemia; Insulin; Male; Movement Di | 1972 |
Similarity of diazepam to diphenylhydantoin.
Topics: Diazepam; Humans; Phenytoin; Seizures; Structure-Activity Relationship; Tremor | 1971 |